Menu
GWAS Study

Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.

Ransohoff KJ, Wu W, Cho HG et al.

28212542 PubMed ID
GWAS Study Type
294237 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RK
Ransohoff KJ
WW
Wu W
CH
Cho HG
CH
Chahal HC
LY
Lin Y
DH
Dai HJ
AC
Amos CI
LJ
Lee JE
TJ
Tang JY
HD
Hinds DA
HJ
Han J
WQ
Wei Q
SK
Sarin KY
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies have identified 21 susceptibility loci associated with melanoma. These loci implicate genes affecting pigmentation, nevus count, telomere maintenance, and DNA repair in melanoma risk. Here, we report the results of a two-stage genome-wide association study of melanoma. The stage 1 discovery phase consisted of 4,842 self-reported melanoma cases and 286,565 controls of European ancestry from the 23andMe research cohort and the stage 2 replication phase consisted of 1,804 melanoma cases and 1,026 controls from the University of Texas M.D. Anderson Cancer Center. We performed a combined meta-analysis totaling 6,628 melanoma cases and 287,591 controls. Our study replicates 20 of 21 previously known melanoma-loci and confirms the association of the telomerase reverse transcriptase, TERT, with melanoma susceptibility at genome-wide significance. In addition, we uncover a novel polymorphism, rs187843643 (OR = 1.96; 95% CI = [1.54, 2.48]; P = 3.53 x 10-8), associated with melanoma. The SNP rs187842643 lies within a noncoding RNA 177kb downstream of BASP1 (brain associated protein-1). We find that BASP1 expression is suppressed in melanoma as compared with benign nevi, providing additional evidence for a putative role in melanoma pathogenesis.

4,842 European ancestry cases, 286,565 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

294237
Total Participants
GWAS
Study Type
Yes
Replicated
1,804 European ancestry cases, 1,026 European ancestry controls
Replication Participants
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.